As of 2025-07-19, the Intrinsic Value of Trilogy International Partners Inc (TRL.TO) is 278.90 CAD. This TRL.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.23 CAD, the upside of Trilogy International Partners Inc is 121,160.20%.
The range of the Intrinsic Value is 224.31 - 373.00 CAD
Based on its market price of 0.23 CAD and our intrinsic valuation, Trilogy International Partners Inc (TRL.TO) is undervalued by 121,160.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 224.31 - 373.00 | 278.90 | 121160.2% |
| DCF (Growth 10y) | 252.97 - 413.78 | 312.32 | 135689.5% |
| DCF (EBITDA 5y) | 241.90 - 280.85 | 259.99 | 112940.8% |
| DCF (EBITDA 10y) | 266.54 - 332.95 | 296.88 | 128976.9% |
| Fair Value | 167.40 - 167.40 | 167.40 | 72,682.70% |
| P/E | 115.71 - 394.76 | 264.99 | 115114.4% |
| EV/EBITDA | 7.02 - 170.32 | 82.72 | 35863.6% |
| EPV | 15.47 - 22.31 | 18.89 | 8113.0% |
| DDM - Stable | 32.98 - 85.93 | 59.45 | 25749.5% |
| DDM - Multi | 88.31 - 202.96 | 125.67 | 54539.5% |
| Market Cap (mil) | 20.38 |
| Beta | 1.20 |
| Outstanding shares (mil) | 88.63 |
| Enterprise Value (mil) | -21.06 |
| Market risk premium | 5.50% |
| Cost of Equity | 11.09% |
| Cost of Debt | 5.00% |
| WACC | 7.82% |